Parkway Minerals NL Overview
Parkway Corporate is an Australian micro-cap that has moved from a failed potash explorer into a vertically integrated industrial water, wastewater and brine-processing group. It runs two linked divisions. Industrial Operations (Parkway Process Solutions, "PPS", including the acquired Tankweld business) sells water-treatment products and delivers engineering, fabrication, installation and structural-mechanical-piping (SMP) work to municipal, mining, energy and industrial clients. It generated record FY26 revenue of A$19.87M. Process Technologies (Parkway Process Technologies, "PPT", and Queensland Brine Solutions, "QBS") owns a proprietary portfolio led by the patented iBC® (integrated Brine Causticisation) and aMES® processes. These target conversion of regulated waste brines, principally from Queensland coal seam gas (CSG), into caustic soda, hydrochloric acid and other chemicals. The investment case depends on QBS's staged QBS Brine Management Complex (QBMC). QBMC received development approval on 20 August 2026, and the company quotes preliminary Stage 1 metrics of an IRR above 30% and a post-tax NPV above A$700M. The operating business is near break-even and carries a going-concern uncertainty flag.
Company's own description (FY26 Annual Report, paraphrased)
The FY26 Annual Report describes Parkway as an Australian water, wastewater treatment and process technology company. It says the company focuses on commercialising innovative process technologies in key industrial markets, which it sees as an effective way to address global water-related sustainability problems. In FY26 the company reported two principal activities:
-
Process Technologies Division: commercialisation of proprietary water, wastewater and brine-processing technologies, with applications in energy and mining.
-
Industrial Operations Division: conventional water and wastewater treatment products and services, including fabrication and project delivery (with installation), which supports the Process Technologies Division.
Management states that as Industrial Operations scales, it becomes the delivery platform for commercialising PPT's technologies. Over FY26 the company says it built capability across the whole project lifecycle: process development, equipment selection, engineering, procurement, fabrication, installation and commissioning.
Business model and revenue model
| Revenue stream | Nature | Recognition basis (per accounting policy) | Approx. share of revenue |
|---|---|---|---|
| Water-treatment product sales (instrumentation, controllers, pipe/hose/fittings, valves, filters, membranes, tanks; PPS Digital online sales) | Product / distribution | Point in time, as invoiced; 30-day terms | NPD. PPS Digital passed A$1.0M trailing-12-month revenue in Q4-FY26 |
| Engineering, fabrication, installation, SMP project execution (Tankweld) | Project services, fixed price or hourly rate | Over time, by milestone or percentage of completion | Majority of FY25–FY26 revenue (inferred from management commentary; exact split NPD) |
| Technology services (feasibility studies, piloting, analytical testing, process development) | Technical services and consulting | Point in time / milestone | Small; e.g. about A$615k QGC (Shell) feasibility study, aMES piloting for a global miner |
| Prospective: QBMC liquid-waste-management fees plus chemical sales | Infrastructure tolling plus commodity chemicals | Not yet earning | Nil today |
| Prospective: PH-UHBCS modular systems with Hitachi; licensing | Equipment sales / licensing | Not yet earning | Nil today |
There is no subscription revenue. Licensing has been discussed as a possible model for the CSG brine technology in the 2023 Master Plan but has not been contracted.
Value-chain position
Today Parkway is mainly a Tier-2 subcontractor and specialist supplier. Its flagship FY26 contract was SMP scope for a tier-1 engineering and construction contractor on one of Australia's largest municipal resource-recovery projects. The QBMC strategy would move it into asset ownership and operation: QBS would own and run a regulated waste facility that charges waste-management fees to CSG producers and sells chemicals made from the waste. That means moving from a low-margin service provider to an infrastructure-style owner.
Customer types and end-markets
The FY26 report lists municipal water authorities, major engineering contractors, energy companies (notably CSG/LNG), mining companies and other industrial clients. Named or identifiable counterparties include QGC Pty Limited (Shell Group), an unnamed tier-1 engineering contractor (about A$12.85M SMP contract), an unnamed global mining company (aMES piloting and an A$2M mine-dewatering contract), and Worley (strategic partner). All revenue is earned in Australia.
Independent characterisation
Parkway is best understood as a sub-scale engineering-and-fabrication contractor carrying an early-stage infrastructure development option. The operating business has grown fast (revenue up about 61x from FY21 to FY26). However, that growth came mostly from acquisitions (Multi-Wet, Mawpump, Tankweld) and one large contract. Margins have compressed as contracting mix rose: gross margin was 24.0% in FY26 against 31.6% in FY25. Statutory profitability has not been sustained: a maiden A$15,915 profit in FY25 was followed by a A$417,754 loss in FY26.
The equity value depends overwhelmingly on QBMC. QBMC has strong regulatory tailwinds and now has primary approvals, but it has no funding, no binding offtake or brine-supply contracts disclosed, and no final investment decision. Against a market capitalisation of about A$30M, the gap between this and the company's own NPV claim reflects the market's discount for execution and financing risk.
Strategy
Stated strategy (FY25–FY26 Annual Reports, paraphrased)
-
Dual-pronged model: use the Industrial Operations division for proven, revenue-generating water-treatment solutions while developing highly innovative solutions in the technology division. Operations is meant to fund and de-risk technology commercialisation.
-
Integrated EPC capability: build a fully in-house turnkey capability (engineering, procurement, construction) so Parkway can deploy first-of-a-kind technology on its own projects.
-
QBS as the CSG "Best Available Technology": offer an industry-wide alternative to salt encapsulation for Queensland CSG waste brine, converting waste to chemicals in line with the waste hierarchy and circular-economy policy.
-
Modular productisation: standardise pre-treatment, concentration, crystallisation and chemical-synthesis modules (including PH-UHBCS with Hitachi) to serve QBMC and give a nearer-term route to market with third parties.
-
Feedstock diversification: extend QBMC beyond CSG to mining, industrial and municipal brines; FY26 testing of nearby non-CSG brines was encouraging.
-
Disciplined capital allocation: FY27 priorities are to complete the major municipal project, convert the PPS pipeline, advance PH-UHBCS, finalise engineering for the QBMC Stage 0 demonstration project, secure remaining permits, and progress partnering and funding.
Initiatives announced in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Description | Target / metric |
|---|---|---|---|
| Automated welding and plant investment | FY25 | Investment in vehicles, equipment and automated welding technology | Safety, efficiency, capacity |
| E-commerce acquisition (PPS Digital) | 11 Aug 2025 | Assets of a small online business (under A$0.1M) | PPS Digital over A$1.0M TTM revenue (Q4-FY26) |
| QBMC–QBEC integrated design | Sep 2025 quarter | Brine management and electrochemical units combined on one site as preferred configuration | Process synergies |
| QBMC site | Oct 2025 | 10 ha binding option to lease | — |
| QBMC Stage 1 economics | Around Nov 2025 AGM | Preliminary metrics | IRR above 30%; post-tax NPV above A$700M at 10%; about 75,000 t/yr contained salts per stage |
| Minor restructuring | Dec 2025 quarter – FY26 | Restructure to improve profitability; PPS-Perth restructured; Perth lease surrendered | Scalable operating model |
| DA lodgement | 22 Dec 2025 | Stages 0 and 1 | Approved 20 Aug 2026 |
| Hitachi PH-UHBCS | May 2026 | Binding MoU for co-development and commercialisation | Modular product range for QBMC and third parties |
| Regulatory review | Released Aug 2026 | Commissioned review of the policy and regulatory framework for CSG brines | Supports the business case |
| Board renewal | Aug 2026 | Engineering and commercialisation skills added for the scale-up phase | — |
ESG / sustainability commitments: ISO 9001 (quality), ISO 14001 (environment) and ISO 45001 (OH&S) certified integrated management system (PIMS), recertified annually. No emissions targets have been published.
Medium-term financial guidance: none in quantified form. Qualitative guidance for FY27 is that revenue growth will moderate from Q2-FY27 as the major municipal project nears completion, with the company relying on the project backlog and opportunity pipeline.
Products & Services
Industrial Operations (PPS / Tankweld)
| Offering | Description | Target customer | Launch / status | Pricing |
|---|---|---|---|---|
| Instrumentation and controllers | Devices that measure, monitor and automate water-treatment operations | Industrial, municipal, mining | Core PPS range (Mawpump/Multi-Wet heritage) | Transactional, NPD |
| Pipe, hose and fittings | Fluid-handling components | Industrial and contractor | Core range | Transactional |
| Valves and solenoids | Flow-control components | Industrial | Core range | Transactional |
| Filters, membranes and process equipment | Filtration and separation equipment | Industrial water treatment | Core range | Transactional |
| Tanks | Industrial water-treatment and process tanks; Tankweld designs and builds large steel tanks | Water utilities, industrial | Tankweld heritage | Project / quote |
| Heavy-duty steel pallets | Steel pallets for storage and transport of goods | Industrial logistics | Listed in company profile | Transactional |
| PPS Digital (e-commerce) | Online sales of water-industry and industrial analytical equipment; expanded via a small e-commerce asset acquisition (11 Aug 2025, under A$0.1M) | SMEs, labs, industrial buyers | Passed A$1.0M TTM revenue in Q4-FY26 | Online list prices |
| Analytical testing and process development | Laboratory testing and treatability studies | Industrial clients | Ongoing | Fee-for-service |
| Engineering and project management | Design, project definition, procurement | Municipal, mining, energy | Ongoing | Fixed price or hourly |
| Workshop fabrication | Specialised fabrication; investment in automated welding technology (FY25) | Contractors, utilities | Tankweld 4,600 m² facility, Melbourne | Project |
| Site installation and SMP execution | Structural, mechanical and piping installation | Tier-1 contractors, utilities | Flagship: about A$12.85M municipal resource-recovery SMP scope (awarded June 2024; executed FY25–FY27) | Contract |
| Mine dewatering | Delivery of dewatering scope for a global miner | Mining majors | A$2M contract, 31 Aug 2026, completion due 30 Nov 2026 | Contract |
| Operation and maintenance | O&M of treatment assets | Industrial, municipal | Listed service | Contract |
Process Technologies (PPT / QBS)
| Technology / offering | Description | Target customer | Status | Commercial model |
|---|---|---|---|---|
| iBC® (integrated Brine Causticisation) | Patented process that treats complex brines and converts their salts into industrial chemicals such as caustic soda. CSIRO GISERA's June 2026 analysis named a causticisation pathway that Parkway says is based on iBC® | CSG producers; industrial brine generators | Piloted; basis of QGC feasibility study (completed Mar 2023) and QBMC | Licensing or ownership (QBMC) |
| aMES® (activated Mineral Extraction System) | Recovers minerals and reagents from concentrated brines | Mining and critical minerals; CSG | Piloting for a global mining company's international critical-minerals project concluded successfully (FY25) | Technology services; potential licensing |
| Salt-splitting technology | Process used on CSG-derived brines to produce mineral acid (HCl) and caustic | CSG | Production of mineral acid from CSG brine demonstrated (FY24) | Part of QBMC/QBEC |
| Upstream brine concentration and beneficiation package | Modular on-site pre-treatment and first-stage concentration, using iBC®/aMES® IP; offered on a tolling basis with Worley | CSG operators (up to about 12 sites per company) | Bench-piloted, being scaled up (Aug 2023) | Tolling |
| Modular product range | Standardised brine pre-treatment, concentration, crystallisation and chemical-synthesis modules | QBMC and third parties | Development (FY26) | Equipment sale or lease |
| PH-UHBCS (Parkway Hitachi Ultra-High Brine Concentration Systems) | Standardised modular ultra-high brine concentrators co-developed under a binding MoU with Hitachi Aqua-Tech Engineering (May 2026) | QBMC (downstream), customer sites (upstream), Australian and international markets | Development; talks with several parties on off-site use | Product sales (economics NPD) |
| QBS Brine Management Complex (QBMC) | Staged regulated facility in the Western Downs (QLD) that receives CSG and other waste brines/salts, recovers water and converts salts to chemicals. Stage 0 is a Commercial Demonstration Project; Stages 1–4 are each about 75,000 t/yr of contained salt. At full scale, Parkway says it could process all existing and forecast Queensland CSG salts | CSG producers (QGC, APLNG, Santos/GLNG, Arrow), mining, industrial and municipal brine generators | DA approved 20 Aug 2026; EA and road permit 16 Jun 2026; FID, funding and commercial agreements outstanding | Waste-management fees plus chemical sales (NaOH, HCl, others). Company metrics for Stage 1: IRR above 30%, post-tax NPV above A$700M at 10% (preliminary) |
| QBS Brine Electrochemical Complex (QBEC) | Downstream electrochemical conversion of concentrated brine/salts into green chemicals; integrated with QBMC on one site (preferred configuration from Sep 2025 quarter) | As above | Concept / design | Chemicals sales |
| Parkway Centre for Brine Technologies | Piloting and R&D facility co-located with Victoria University's ISILC | Internal and clients | Operating | Supports services |
Financial Narrative
All figures A$ millions unless stated, from audited annual reports (FY22–FY23 from the FY23 AR; FY24–FY25 from the FY25 AR; FY26 and restated FY25 balance sheet from the FY26 AR). EBITDA and EBIT are derived by the analyst as statutory profit before tax plus interest expense, minus interest income, plus depreciation and amortisation. The company does not publish a reconciled statutory EBITDA. Management-reported EBITDA differs (see commentary). Blank cells mean not available or not meaningful.
Income statement
Revenue CAGR. FY22–FY26 (4 years): about 55.7% a year. FY21 (A$0.33M, per FY25 AGM presentation) to FY26: about 127% a year. FY21 net loss was A$0.92M (FY23 AR performance table).
Commentary.
Scale-up: Revenue rose from A$0.33M in FY21 to A$19.87M in FY26. This came from acquisitions (Multi-Wet Feb 2021, Mawpump Sep 2021, Tankweld Mar 2024) and from one contract (the about A$12.85M municipal SMP scope awarded June 2024, executed mainly in FY25–FY26). Tankweld alone had reported about A$16.5M revenue and about A$2M EBITDA in its own FY23 before acquisition (GOLDINVEST, sponsored). So most of the FY24–FY26 growth is consolidation of an acquired business rather than organic growth in Parkway's original activities.
Margin compression: Gross margin fell from 31.6% (FY25) to 24.0% (FY26) as lower-margin site-installation work on the major project dominated H2-FY26. FY26 gross profit (A$4.76M) was slightly below FY25 (A$4.79M) despite 31% more revenue. That is the clearest sign the extra volume added no gross profit.
Profitability inflection, then reversal: Derived EBITDA turned positive in FY24 (A$0.02M), reached A$1.52M in FY25 (consistent with the company's preliminary FY25 EBITDA of about A$1.52M), then fell to A$1.09M in FY26. GOLDINVEST's July 2026 note, citing the June 2026 quarterly chart based on unaudited management accounts, says EBITDA was "around A$2 million" in each of FY25 and FY26. The HY26 quarterly cites a rolling 12-month EBITDA of A$1.92M. Discrepancy: management EBITDA appears to be an adjusted figure, probably including the R&D tax incentive (about A$0.9M a year, which is largely credited against capitalised development costs rather than to the income statement) and excluding certain items. Analysts should rely on the statutory derivation.
Interest burden: Interest expense rose from A$0.05M (FY23) to about A$0.62–0.65M (FY25–FY26). This mainly reflects AASB 16 interest on the Tankweld-era leases (lease liabilities about A$5–7M) plus the term loan. Interest consumed about 40% of FY25 EBITDA and 57% of FY26 EBITDA.
H1/H2 phasing: HY26 (to Dec 2025) sales revenue was A$7.27M with a A$0.53M loss before tax, hurt by temporary site-access problems on the major project that deferred revenue. H2-FY26 delivered about A$12.6M revenue and a small profit.
Balance sheet
FY25 is shown as restated in the FY26 AR. As originally reported in the FY25 AR: total assets A$26.10M, intangibles A$10.65M, equity A$15.73M. Negative net debt means net cash.
Commentary.
Liquidity tightening: Working capital fell from A$4.74M to A$2.45M and the current ratio from 2.52x to 1.36x. The main cause is reclassification of the A$2.0M term loan to current liabilities, plus a A$1.64M rise in trade payables. The loan's maturity was extended by one year; a further A$1.0M acquisition facility is available subject to lender approval. The lender is not named in the material reviewed.
Going concern: The FY26 report says the financial position should be read with the significant uncertainty relating to going concern disclosed in Note 2(a). This is a new and material change: the FY23 and FY25 notes contained no such uncertainty.
Intangible-heavy balance sheet: Intangibles (A$9.51M) are 69% of equity. They comprise capitalised development of not-yet-in-use technology (iBC®, aMES®), acquired IP (Victoria University portfolio, iBC®) and acquisition goodwill (Tankweld, Mawpump). Assets not yet available for use are tested annually but not amortised, so the carrying value depends on QBMC and related plans going ahead.
Lease liabilities: (A$5.21M) are the largest financing obligation. They reflect long-dated Sunshine North premises leases (rent reviews to A$119,160 a year on both Warehouse 4 and Warehouse 5 in 2026), with extension options assumed exercised. The Perth premises lease was surrendered on 10 May 2026.
Cash flow
FY26 figures are from the Chairman's Letter and Operating and Financial Review: OCF A$1.69M and investing outflow A$1.28M (PP&E plus capitalised technology development, split NPD). FY26 FCF uses total investing outflows as the proxy. FinancialFilings shows FY26 cash from operations of A$1.34M "per the quarterly report", a discrepancy with the audited A$1.69M; the audited figure is preferred. FY22–FY23 statements had no capitalised R&D line. FY21 OCF was about -A$2.45M (company chart cited by GOLDINVEST).
Commentary. Operating cash flow has improved every year since FY22 and FY26 delivered the first positive free cash flow (about A$0.41M). However, the cash build in FY26 (+A$0.35M) relied partly on working-capital timing: payables up A$1.6M, and a strong A$7.42M of customer receipts in Q4. Management expects revenue growth to moderate from Q2-FY27 as the major project winds down, so this cash generation may not recur. FY24 was funded by about A$6.25M of equity (August 2023 placement of A$4.0M plus further issues), which paid for Tankweld. The QBMC Stage 0 and later stages will need external capital far larger than the current balance sheet; the size is not disclosed.
Ratios
CCC = DSO + DIO - DPO, using year-end balances against revenue and COGS. FY24 is distorted by part-year Tankweld consolidation. FY22–FY23 are not meaningful because of the different COGS classification. Interest coverage is not meaningful where EBIT is negative.
Ratio commentary. Returns on capital remain negligible even at peak revenue. Interest coverage below 1x in both profitable-EBITDA years shows the lease-heavy cost base absorbs most operating earnings. The improvement in asset turnover (0.27x to 0.77x) and the shorter cash conversion cycle (107 to 31 days) are real operational gains from scaling through a fixed asset base. The FY26 cycle is flattered by stretched payables (DPO about 88 days).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Division Overview
| Division | Legal vehicles | Contents | Products / services |
|---|---|---|---|
Industrial Operations | Parkway Process Solutions Pty Ltd ("PPS"); Tankweld Engineering Service Pty Ltd; Tankweld Installations Pty Ltd; PPS Digital (e-commerce channel); legacy Mawpump and Multi-Wet businesses (integration status NPD) | Conventional water/wastewater products; engineered solutions; workshop fabrication; site installation; SMP project execution; project management | Instrumentation and controllers, pipe/hose/fittings, valves and solenoids, filters and membranes, tanks, heavy-duty steel pallets, analytical equipment; engineering, fabrication, installation, O&M |
Process Technologies (called "Industrial Technology Division" in FY25) | Parkway Process Technologies Pty Ltd ("PPT"); Queensland Brine Solutions Pty Ltd ("QBS") | Proprietary process R&D, piloting, technoeconomic evaluation, scale-up and partnering; QBMC development | iBC®, aMES®, salt-splitting technology, upstream brine concentration package, modular pre-treatment / concentration / crystallisation / chemical synthesis range, PH-UHBCS (with Hitachi), QBMC/QBEC |
Legacy resources (Parkway Ventures) | Parkway Ventures Pty Ltd; Consolidated Potash Corporation Pty Ltd | 40% interest in Karinga Lakes Potash Project JV (NT) with Verdant Minerals; Dandaragan Trough tenements (WA) | Non-core; no substantive exploration in FY23–FY25. Future of KLPP described as highly uncertain after a native-title determination (FY23 AR) |
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Group sales revenue, all divisions (AUD Mn) | 3.38 | 4.25 | 8.90 | 15.14 | 19.87 |
Group revenue growth YoY (%) | 931.4 | 25.8 | 109.5 | 70.2 | 31.2 |
Group gross margin (%) | 55.6 | 60.9 | 27.3 | 31.6 | 24.0 |
Revenue by Segment
| Metric | Q1-FY26 | Q2-FY26 | Q3-FY26 | Q4-FY26 |
|---|---|---|---|---|
Operating revenue (AUD Mn) | 3.63 | 3.64 | 5.21 | 7.25 |
EBITDA (AUD Mn) | — | — | — | 0.54 |
Net operating cash flow (AUD Mn) | — | — | -0.08 | 1.60 |
Quarter-end cash (AUD Mn) | — | 1.91 | 1.70 | 2.89 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Per-Share Data
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Sales revenue (AUD Mn) | 3.38 | 4.25 | 8.90 | 15.14 | 19.87 |
Cost of goods sold (AUD Mn) | 1.50 | 1.66 | 6.47 | 10.35 | 15.10 |
Gross profit (AUD Mn) | 1.88 | 2.59 | 2.43 | 4.79 | 4.76 |
Government grants and other income (AUD Mn) | 0.33 | 0.44 | 0.64 | 0.07 | 0.07 |
Employee expenses (AUD Mn) | 2.71 | 2.91 | 1.81 | 2.18 | 2.23 |
Depreciation and amortisation (AUD Mn) | 0.27 | 0.43 | 0.59 | 0.94 | 0.93 |
EBITDA, derived (AUD Mn) | -2.04 | -1.21 | 0.02 | 1.52 | 1.09 |
Operating income / EBIT, derived (AUD Mn) | -2.31 | -1.64 | -0.57 | 0.58 | 0.16 |
Interest expense (AUD Mn) | 0.02 | 0.05 | 0.25 | 0.65 | 0.62 |
Pre-tax income (AUD Mn) | -2.33 | -1.68 | -0.73 | 0.02 | -0.42 |
Net income (AUD Mn) | -2.33 | -1.68 | -0.73 | 0.02 | -0.42 |
EPS basic (A$ cents) | -0.11 | -0.08 | -0.03 | 0.001 | -0.015 |
EPS diluted (A$ cents) | -0.11 | -0.08 | -0.03 | 0.001 | -0.015 |
Dividends per share (A$ cents) | 0 | 0 | 0 | 0 | 0 |
Gross margin (%) | 55.6 | 60.9 | 27.3 | 31.6 | 24.0 |
EBITDA margin (%) | -60.5 | -28.6 | 0.2 | 10.0 | 5.5 |
Operating (EBIT) margin (%) | -68.5 | -38.7 | -6.4 | 3.8 | 0.8 |
Net margin (%) | -69.1 | -39.6 | -8.3 | 0.1 | -2.1 |
Revenue growth YoY (%) | 931.4 | 25.8 | 109.5 | 70.2 | 31.2 |
Balance Sheet
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | 12.67 | 11.96 | 26.92 | 24.15 | 25.71 |
Cash and equivalents (AUD Mn) | 4.00 | 2.00 | 3.49 | 2.58 | 2.93 |
Trade and other receivables, current (AUD Mn) | 0.62 | 0.43 | 3.77 | 3.75 | 3.95 |
Inventories (AUD Mn) | 1.52 | 1.68 | 1.79 | 1.46 | 1.93 |
Goodwill and intangibles (AUD Mn) | 4.90 | 4.62 | 9.58 | 8.70 | 9.51 |
Right-of-use assets (AUD Mn) | 1.19 | 2.71 | 6.66 | 6.02 | 4.72 |
Short-term borrowings (AUD Mn) | 0 | 0 | 0.12 | 0.03 | 2.02 |
Long-term borrowings (AUD Mn) | 0 | 0 | 1.00 | 1.00 | 0 |
Lease liabilities, total (AUD Mn) | 1.22 | 2.80 | 6.80 | 6.37 | 5.21 |
Net debt excl. leases (AUD Mn) | -4.00 | -2.00 | -2.38 | -1.55 | -0.91 |
Net debt incl. leases (AUD Mn) | -2.79 | 0.79 | 4.42 | 4.82 | 4.30 |
Total equity (AUD Mn) | 9.69 | 8.17 | 15.49 | 13.78 | 13.77 |
Accumulated losses (AUD Mn) | -26.96 | -28.64 | -29.38 | -29.36 | -29.78 |
Working capital (AUD Mn) | 4.29 | 3.03 | 5.46 | 4.74 | 2.45 |
Cash Flow
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | -2.12 | -1.34 | 0.64 | 0.96 | 1.69 |
Capex, plant and equipment (AUD Mn) | 0.08 | 0.14 | 0.17 | 0.40 | — |
Capitalised R&D (AUD Mn) | 0 | 0 | 1.27 | 1.00 | — |
Total investing cash flow (AUD Mn) | -1.34 | -0.44 | -3.78 | -1.36 | -1.28 |
Acquisitions, net cash paid (AUD Mn) | 1.23 | 0.26 | 2.35 | 0 | — |
Free cash flow, OCF less capex and capitalised R&D (AUD Mn) | -2.20 | -1.48 | -0.81 | -0.45 | 0.41 |
Equity issued, net (AUD Mn) | 0.01 | 0 | 5.96 | 0 | 0.02 |
Lease principal repaid (AUD Mn) | 0 | 0.23 | 0.55 | 0.42 | — |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
ROE, on year-end equity (%) | -24.1 | -20.6 | -4.7 | 0.1 | -3.0 |
ROA, on year-end assets (%) | -18.4 | -14.0 | -2.7 | 0.1 | -1.6 |
ROIC, pre-tax EBIT over (equity + debt + leases - cash) (%) | -33.4 | -18.3 | -2.9 | 3.1 | 0.9 |
Current ratio (x) | 3.22 | 3.62 | 2.45 | 2.52 | 1.36 |
Debt to equity, borrowings only (x) | 0 | 0 | 0.07 | 0.07 | 0.15 |
Debt plus leases to equity (x) | 0.13 | 0.34 | 0.51 | 0.54 | 0.53 |
Net debt incl. leases to EBITDA (x) | — | — | — | 3.2 | 3.9 |
Interest coverage, EBIT over interest (x) | — | — | — | 0.9 | 0.3 |
Asset turnover, revenue over total assets (x) | 0.27 | 0.36 | 0.33 | 0.63 | 0.77 |
Cash conversion cycle (days) | — | — | 106.8 | 71.0 | 31.3 |
Revenue by Region and Region Margins & Growth (%)
| Region | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Australia revenue (AUD Mn) | 3.38 | 4.25 | 8.90 | 15.14 | 19.87 |
Rest of world revenue (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Australia growth YoY (%) | 931.4 | 25.8 | 109.5 | 70.2 | 31.2 |
Per-Share Data and Income Statement
| Metric | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
Share price at 30 June (A$ cents) | 0.4 | 0.7 | 1.0 | 1.0 | 1.0 | 0.8 | 1.2 | 1.0 |
Net profit after tax (AUD Mn) | -2.01 | -2.42 | -0.92 | -2.33 | -1.68 | -0.73 | 0.02 | -0.42 |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
EV (incl. leases) | About A$34.8M | Market cap A$30.5M + debt A$2.02M + leases A$5.21M - cash A$2.93M |
EV (excl. leases) | About A$29.6M | — |
EV/Sales FY26 | About 1.75x (incl. leases) / 1.49x (excl.) | Revenue A$19.87M |
EV/EBITDA FY26 | About 32x (derived EBITDA A$1.09M); about 17x on management's about A$2M | Discrepancy noted |
P/B | About 2.2x | Equity A$13.77M |
Price / tangible book | About 7.3x | Tangible equity about A$4.27M |
Capital Markets
| Item | Status |
|---|---|
Analyst consensus | None; no sell-side coverage. Simply Wall St reports zero analysts. GOLDINVEST is paid sponsored research and should not be treated as independent |
Dividend history and policy | No dividend ever paid; none recommended for FY26 |
Credit ratings (Moody's / S&P / Fitch) | None (unrated) |
Debt profile | A$2.0M senior secured term loan, current at 30 June 2026, maturity extended one year (exact date NPD); A$1.0M acquisition facility undrawn, subject to lender approval; lease liabilities A$5.21M (A$0.44M current) |
Options overhang | 125M options at A$0.015 expiring 16 May 2027 (about 36% above a 1.1c price) |
Recent equity issuance | Aug 2023 placement A$4.0M at 1.4c; Jan 2021 A$5.25M |
Liquidity | Thin; ASX average daily value traded at times only hundreds of dollars (StockLight snapshot) |
Other venues | Frankfurt (4IP); German retail interest visible on Lang & Schwarz / Börsennews |
Analyst Conclusions
Management guidance (FY26 AR and Jun-2026 quarterly)
-
Revenue growth expected to moderate from Q2-FY27 as the major municipal resource-recovery project nears completion.
-
FY27 priorities: complete the major project; convert the PPS pipeline; advance PH-UHBCS with Hitachi; finalise engineering for the QBMC Stage 0 Commercial Demonstration Project; secure remaining permits; progress commercial partnering and funding.
-
No quantified revenue, EBITDA or capex guidance.
Consensus
None.
Bull case
-
Approvals moat converts to contracts. With the EA and DA in hand (Jun and Aug 2026), QBMC may be the only permitted pathway for CSG brine to chemicals in Queensland. Even one producer agreement for Stage 0 would support the company's above-A$700M Stage 1 NPV claim against a A$30M market cap.
-
Strategic partnering at project level. Hitachi's involvement, Worley's history with the project and Shell/QGC's paid feasibility study make a well-capitalised partner farming into QBS plausible. That would crystallise value with limited parent dilution.
-
Operating business is self-funding. Record Q4-FY26 OCF of A$1.60M, FY26 OCF of A$1.69M, first positive FCF, and new work (A$2M dewatering, PPS Digital over A$1M TTM) suggest the core business can cover overheads while QBMC advances.
Bear case
-
Funding gap and going concern. With A$2.9M cash, a current A$2.0M loan and a disclosed going-concern uncertainty, Parkway cannot fund Stage 0, let alone Stage 1. Equity at about 1c implies heavy dilution.
-
Revenue cliff and margin dilution. FY26 growth was concentrated in one contract that is winding down. Gross profit was flat on 31% more revenue, and the statutory result turned to a loss. FY27 could show falling revenue and wider losses.
-
No commercial proof yet. No brine-supply agreement, offtake contract, capex estimate or FID is disclosed. CSG majors could keep brine in ponds or choose encapsulation or a global ZLD vendor. The A$9.5M intangible base could then be impaired.
Key catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Expected timing | Why it matters |
|---|---|---|
| 2025-26 AGM (resolutions on director elections, remuneration, possible placement capacity) | About late Nov 2026 | Board endorsement; capital-raising mandate |
| Sep-2026 quarterly (Appendix 4C) | By end Oct 2026 | First quarter after major-project peak; cash runway |
| Completion of A$2M dewatering contract | 30 Nov 2026 | Revenue backfill |
| Term-loan refinancing or extension | FY27 | Removes going-concern pressure |
| QBMC Stage 0 engineering, capex estimate and funding | FY27 | First quantified capital need |
| Binding brine-supply or offtake agreements with CSG producers | Unspecified | Critical to proving demand |
| Strategic partner or QBS-level investment | Talks cited Jul 2026 | Value crystallisation |
| PH-UHBCS first orders | Unspecified | Nearer-term technology revenue |
| HY27 results (Dec 2026 half) | Late Feb 2027 | Margin and revenue after the project |
| Expiry of 125M options at 1.5c | 16 May 2027 | Possible cash inflow if exercised; otherwise overhang removed |
Analyst verdict
Parkway Corporate has turned a failed potash explorer into a credible, if small, industrial water business. Revenue rose from A$0.33M in FY21 to A$19.87M in FY26, operating cash flow is positive, and the company assembled real fabrication and SMP capability by buying Tankweld. The weakness is that this growth has not produced durable earnings. The FY25 maiden profit of A$15,915 was followed by a A$0.42M loss in FY26. Gross profit did not grow despite 31% more revenue. Interest and lease costs absorb most of EBITDA. The audited accounts now carry a going-concern material uncertainty, the term loan is current, and the FY25 balance sheet has been restated downward by A$1.95M. With growth guided to slow from Q2-FY27, the operating business looks like a break-even platform rather than a profit engine.
The investment case is therefore almost entirely about QBMC. Here Parkway has achieved more than most micro-caps: a site, an Environmental Authority, a council-approved DA for a first-of-a-kind regulated CSG brine-to-chemicals facility, a binding MoU with Hitachi, and independent support from CSIRO GISERA's analysis of brine options. The structural problem is real: about 6 Mt of salts awaiting a solution, with no encapsulation facility permitted. But between approval and value lie four unresolved conditions: brine-supply contracts, chemical offtake, a disclosed capex estimate, and funding at a scale far beyond Parkway's A$13.8M equity base.
On balance, PWN is a high-risk, binary development option, not a fundamentals-backed growth stock. The roughly 1.7x EV/Sales and 2.2x P/B multiples mean little. What matters is whether a well-capitalised partner commits capital at the QBS level within the next 12–18 months. Until that happens, investors should expect continued dilution risk and treat the company's above-A$700M NPV as preliminary and unfunded. Position sizing should reflect the realistic possibility of a total loss alongside meaningful upside if QBMC is partnered.
APPENDIX — PRINCIPAL SOURCES
1: Parkway Corporate Limited, 2026 Annual Report (lodged 30 Sep 2026), via FinancialFilings.com — FY26 financials, board, remuneration, risks, events, restated FY25
2: Parkway Corporate Limited, 2025 Annual Report (23 Sep 2025), announcements.asx.com.au — FY24–FY25 financials, strategy, remuneration
3: Parkway Corporate Limited, 2023 Annual Report (28 Sep 2023), announcements.asx.com.au — FY22–FY23 financials, history, Master Plan
4: Half-Year Reports: 31 Dec 2024 (27 Feb 2025) and 31 Dec 2025 (27 Feb 2026) — HY results
5: Quarterly Activity Reports: Oct 2025, Jan 2026, Apr 2026, Jul 2026 (via InvestorPA, InvestSMART, Webull bulletin) — Quarterly data
6: ASX announcements: QBMC site (17 Oct 2025); key approvals (20 Aug 2026); A$2M dewatering contract (31 Aug 2026); QGC feasibility contract; Annual Report relodged (7 Oct 2022) — Newsflow
7: FinancialFilings.com company page (filings list to 7 Oct 2026; identifiers) — Filings register, LEI
8: GOLDINVEST articles (Jul–Aug 2026, FY25 results, Tankweld) — paid sponsored research with disclosed conflicts — Tankweld metrics, management EBITDA, board change
9: SmallCaps (Oct 2025); Stockhead; Resources Roadhouse; FinNews Network; Fertilizer Daily; World Fertilizer — History, name changes
10: StockLight; Simply Wall St; TipRanks (note: TipRanks mislabels fiscal years as December year-ends) — Market data, product list
11: Börsennews / Strawman investor forums — Low-reliability colour only; flagged where used
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Qualifications | Background | Other listed boards (3 yrs) | Shares / rights held |
|---|---|---|---|---|---|---|
Ron Douglas | Non-Executive Chair; Chair of Remuneration Committee; member of Audit & Risk and Nomination | 10 Aug 2026 | BE, FAIM, FAusIMM, MAICD | 45-year career in engineering, construction and project delivery; senior roles at Ausenco, Newcrest, Orica, Rio Tinto, WMC Resources | VHM Limited | Nil / nil |
Bahay Ozcakmak | Group Managing Director & CEO | Executive Director since Oct 2019 (CPC acquisition); MD Agreement 26 Oct 2021 | BSc, MABus, DipFin(Inv.), MAICD | About 20 years as corporate adviser; founder of Activated Water Technologies; CEO of Consolidated Potash Corp until its acquisition by Parkway; Victoria University collaboration since 2015; Adjunct Professor (Mar 2026); former director of Lions Bay Capital (TSXV, 2018–19) and Fidelity Minerals (TSXV, 2019–21) | — | 222,070,534 shares; 12,237,500 performance rights |
Sylvia Tulloch AM | Non-Executive Director; member of all three committees | 10 Aug 2026 | AM, BSc, MSc (Materials Science, UNSW) | Materials scientist; co-founded two companies later listed on ASX; commercialisation of mineral-processing and cleantech technology; government advisory roles; Chair of Griffin Accelerator Holdings | Zeotech Limited (Chair) | Nil / nil |
Executive Leadership Team
| Name | Title | Tenure | Prior roles / education |
|---|---|---|---|
Bahay Ozcakmak | Group MD & CEO | Since Oct 2019 (Executive Director); MD & CEO under 26 Oct 2021 agreement | As above |
Michael Hodgkinson | CFO and Joint Company Secretary | Joined 29 May 2023 as Chief Commercial Officer; CFO from Oct/Nov 2023; Joint Co Sec from 25 Oct 2024 | CPA, BEc, LLB (Hons), EMBA-Global (LBS and Columbia); Citigroup (set up finance and legal at Orbian, SAP JV), Alcatel, Comalco, RayGen, Relectrify |
Operations Manager (name NPD) | Operations | Onboarded FY26 | NPD |
Directors' Remuneration
| Name | Year | Cash salary / fees | Bonus | Leave | Super | Share-based | Total |
|---|---|---|---|---|---|---|---|
B Ozcakmak (MD & CEO) | FY26 | 305,000 | 0 | 10,648 | 36,600 | 8,951 | 361,199 |
B Ozcakmak (MD & CEO) | FY25 | 305,000 | 0 | 17,687 | 35,075 | 34,962 | 392,724 |
M Hodgkinson (CFO) | FY26 | 160,767 | 1,188 | 3,230 | 25,159 | 118,263 | 308,607 |
M Hodgkinson (CFO) | FY25 | 156,712 | 1,192 | 8,099 | 23,510 | 186,303 | 375,816 |
S van der Sluys (Chair, to Jan 2026) | FY26 | 40,461 | 0 | 0 | 4,855 | 32,500 | 77,816 |
A Saridas (NED / interim Chair) | FY26 | 43,439 | 0 | 0 | 5,213 | 32,500 | 81,152 |
P Creswell (NED) | FY26 | 43,439 | 0 | 0 | 5,213 | 32,500 | 81,152 |
Total KMP | FY26 | 593,106 | 1,188 | 13,878 | 77,040 | 224,714 | 909,926 |
Total KMP | FY25 | 624,608 | 1,192 | 25,786 | 77,317 | 221,265 | 950,168 |
Major Shareholders
| Holder | Shares | Approx. % | Note |
|---|---|---|---|
Bahay Ozcakmak and related parties | 222,070,534 | about 8.0 | Plus 12.24M performance rights |
Michael Hodgkinson | 3,888,889 | about 0.1 | Plus 39.39M performance rights |
Lions Bay Capital Inc. (TSXV) | NPD | NPD | Described as a major shareholder since 2019 on investor forums |
Top 20 holders / institutional holders | NPD | NPD | Listed in the FY26 AR Shareholder Information section. No known institutional holder |
Competitive Landscape
Key Competitors
| Competitor | Segment overlap | Listing | Positioning vs Parkway | Revenue (latest) |
|---|---|---|---|---|
Veolia Water Technologies (incl. former Suez WTS) | Brine concentration, ZLD, industrial water EPC | Euronext: VIE | Global scale, full ZLD and evaporator-crystalliser offering; incumbent at CSG water plants | — |
Aquatech International | Brine concentration, ZLD, crystallisation | Private | Global thermal and membrane brine specialist | NPD |
Gradiant | Brine concentration, critical-mineral recovery | Private | Venture-backed brine and minerals technology | NPD |
Saltworks Technologies | Brine concentration, ZLD, lithium/minerals | Private (Canada) | Modular brine concentration; direct overlap with PH-UHBCS | NPD |
Clean TeQ Water | Industrial wastewater, mining water treatment technology | ASX: CNQ | Most comparable ASX-listed water-technology micro-cap | — |
Osmoflo | Desalination, brine and industrial water | Private (Australia) | Established Australian membrane and brine engineering firm | NPD |
Aquatec Maxcon | Water and wastewater design-and-construct | Private (Queensland) | Municipal and industrial D&C competitor in Qld/Vic | NPD |
Cleanaway Waste Management | Liquid and hazardous waste management | ASX: CWY | Australia's largest waste company; potential competitor or partner for regulated brine disposal; former employer of NED Creswell | — |
Downer / Ventia / UGL (CIMIC) | Water infrastructure delivery and O&M | ASX: DOW / VNT; CIMIC | Tier-1 contractors that compete for and also subcontract SMP scope | — |
CSG producers' in-house salt encapsulation (QGC/Shell, APLNG, Santos GLNG, Arrow) | Default brine and salt disposal pathway | Various | Main alternative to QBMC; Parkway says no encapsulation facility has been permitted in Australia | — |
De Nora / chlor-alkali technology suppliers | Electrochemical conversion (QBEC) | BIT: DNR | Technology suppliers rather than competitors; possible QBEC partners | — |
Competitor Detail
| Metric | Parkway (FY26) |
|---|---|
Revenue | A$19.87M |
Revenue growth | +31.2% |
Gross margin | 24.0% |
EBITDA margin (derived) | 5.5% |
R&D intensity | About 7.4% (FY25, incl. capitalised) |



